Santiago Uranga

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

Ainhoa Arbués, Jesús Gonzalo‐Asensio, Dessislava Marinova et al. · Vaccine · 2013 · 254 citations · Full text

Vaccination, Pulmonary Tuberculosis, Vaccine Development +11

ESX-1-induced apoptosis is involved in cell-to-cell spread of<i>Mycobacterium tuberculosis</i>

Henar Alonso, Santiago Uranga, Dessislava Marinova et al. · Cellular Microbiology · 2013 · 141 citations · Full text

Apoptosis, Immunology, Immune Regulation +18

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis

Nacho Aguiló, Jesús Gonzalo‐Asensio, Samuel Álvarez-Arguedas et al. · Nature Communications · 2017 · 134 citations · Full text

Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17–Dependent Mechanism

Nacho Aguiló, Samuel Álvarez-Arguedas, Santiago Uranga et al. · The Journal of Infectious Diseases · 2015 · 132 citations · Full text

New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia

Raquel Tarancón, Jorge Domínguez‐Andrés, Santiago Uranga et al. · PLoS Pathogens · 2020 · 80 citations · Full text

Confers Protection, Trained Immunity, Adaptive Immune System +20